Cryopreserved-thawed Embryo Transfer With or Without Gonadotropin Releasing Hormone Agonist
Cryopreserved-thawed Embryo Transfer in Down or Non-down Regulated Hormonally Controlled Cycles: a Prospective, Randomized Study
Sponsor: Cairo University
Listed as NCT02736032, this PHASE3 trial focuses on Infertility and remains completed. Sponsored by Cairo University, it has been updated 6 times since 2016, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE3
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE3
Status: Active Not Recruiting → Completed
-
Feb 2018 — Jun 2018 [monthly]
Active Not Recruiting PHASE3
Status: Recruiting → Active Not Recruiting
▶ Show 1 earlier version
-
Jan 2017 — Feb 2018 [monthly]
Recruiting PHASE3
First recorded
Mar 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Cairo University
- Kamal Shaeer center of infertility
- Nile Ivf Center, Cairo, Egypt
For direct contact, visit the study record on ClinicalTrials.gov .